statistiche ricercatore

Continente	#
NA - Nord America	989
AS - Asia	471
EU - Europa	412
SA - Sud America	58
Continente sconosciuto - Info sul continente non disponibili	15
AF - Africa	14
OC - Oceania	1
Totale	1.960

Nazione	#
US - Stati Uniti d'America	955
IT - Italia	159
SG - Singapore	156
CN - Cina	92
HK - Hong Kong	62
SE - Svezia	50
DE - Germania	45
BR - Brasile	43
VN - Vietnam	43
GB - Regno Unito	39
BD - Bangladesh	37
FI - Finlandia	32
FR - Francia	25
RU - Federazione Russa	25
CA - Canada	22
IN - India	17
KR - Corea	16
JP - Giappone	10
NL - Olanda	10
MX - Messico	9
ID - Indonesia	7
TR - Turchia	7
AR - Argentina	5
BG - Bulgaria	5
MY - Malesia	5
VE - Venezuela	5
IE - Irlanda	4
IQ - Iraq	4
MA - Marocco	4
SY - Repubblica araba siriana	4
SI - Slovenia	3
AT - Austria	2
CO - Colombia	2
JM - Giamaica	2
LU - Lussemburgo	2
MC - Monaco	2
SD - Sudan	2
TW - Taiwan	2
UA - Ucraina	2
ZA - Sudafrica	2
AE - Emirati Arabi Uniti	1
AO - Angola	1
AU - Australia	1
AZ - Azerbaigian	1
BE - Belgio	1
BF - Burkina Faso	1
CG - Congo	1
CL - Cile	1
CY - Cipro	1
CZ - Repubblica Ceca	1
EC - Ecuador	1
EE - Estonia	1
ES - Italia	1
GR - Grecia	1
GT - Guatemala	1
IR - Iran	1
KE - Kenya	1
KZ - Kazakistan	1
LK - Sri Lanka	1
MD - Moldavia	1
NE - Niger	1
NP - Nepal	1
PH - Filippine	1
PK - Pakistan	1
SK - Slovacchia (Repubblica Slovacca)	1
TN - Tunisia	1
UY - Uruguay	1
Totale	1.945

Nome	#
Use of hydroxychloroquine in hospitalised COVID-19 patients is associated with reduced mortality: Findings from the observational multicentre Italian CORIST study	384
Bloodstream infections caused by carbapenem-resistant Acinetobacter baumannii: Clinical features, therapy and outcome from a multicenter study	375
RAAS inhibitors are not associated with mortality in COVID-19 patients: findings from an observational multicenter study in Italy and a meta-analysis of 19 studies	373
Long-term efficacy of dolutegravir in treatment-experienced subjects failing therapy with HIV-1 integrase strand inhibitor-resistant virus	226
Determinants of virologic and immunologic outcomes in chronically HIV-infected subjects undergoing repeated treatment interruptions: The Istituto Superiore di Sanità-Pulsed Antiretroviral Therapy (ISS-PART) study	215
Incidence and prognosis of ventilator-associated pneumonia in critically ill patients with covid-19: A multicenter study	204
Invasive Meningococcal Disease due to group C N. meningitidis ST11 (cc11): The Tuscany cluster 2015–2016	183
Totale	1.960

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	111	0	0	1	10	4	12	0	6	13	4	35	26
2022/2023	182	27	32	8	17	17	22	10	16	16	0	10	7
2023/2024	111	1	8	12	22	17	5	19	12	1	4	3	7
2024/2025	356	14	4	5	33	60	49	25	16	44	21	35	50
2025/2026	734	61	27	39	80	120	34	88	40	74	52	56	63
2026/2027	141	14	125	2	0	0	0	0	0	0	0	0	0
Totale													1.960